» Articles » PMID: 35822047

Obesity Accelerates Age-Associated Defects in Human B Cells Through a Metabolic Reprogramming Induced by the Fatty Acid Palmitate

Overview
Journal Front Aging
Specialty Geriatrics
Date 2022 Jul 13
PMID 35822047
Authors
Affiliations
Soon will be listed here.
Abstract

We have measured the secretion of autoimmune antibodies in plasma samples and in culture supernatants of blood-derived B cells from four groups of individuals: young lean (Y), elderly lean (E), young obese (Y) and elderly obese (E). We found secretion comparable in Y and E individuals, suggesting that obesity accelerates age-associated defects in circulating B cells. To define at least one possible molecular pathway involved, we used an model in which B cells from Y and E individuals have been stimulated with the Fatty Acid (FA) palmitate, the most common saturated FA in the human body. The rationale to use palmitate is that there is a chronic increase in circulating levels of palmitate, due to increased spontaneous lipolysis occurring during aging and obesity, and this may induce autoimmune B cells. Results herein show that incubation of B cells from Y and E individuals with the FA palmitate induces mRNA expression of T-bet, the transcription factor for autoimmune antibodies, as well as secretion of autoimmune IgG antibodies, with B cells from Y individuals looking similar to B cells from E individuals, confirming our initial hypothesis. The generation of autoimmune B cells in the presence of the FA palmitate was found to be associated with a metabolic reprogramming of B cells from both Y and E individuals. These results altogether show the critical role of the FA palmitate in inducing human B cell immunosenescence and show for the first time the importance of metabolic pathways in this process.

Citing Articles

Oxylipins Derived from PUFAs in Cardiometabolic Diseases: Mechanism of Actions and Possible Nutritional Interactions.

Agagunduz D, Yesildemir O, Kocyigit E, Kocak T, Ozen Unaldi B, Ayakdas G Nutrients. 2024; 16(22).

PMID: 39599599 PMC: 11597274. DOI: 10.3390/nu16223812.


In Vitro Treatment with Metformin Significantly Reduces Senescent B Cells Present in the Adipose Tissue of People with Obesity.

Romero M, Gelsomini A, Miller K, Suresh D, Thaller S, Frasca D J Nutr. 2024; 155(2):445-452.

PMID: 39389182 PMC: 11867121. DOI: 10.1016/j.tjnut.2024.10.013.


Gerotherapeutics: aging mechanism-based pharmaceutical and behavioral interventions to reduce cancer racial and ethnic disparities.

Mandelblatt J, Antoni M, Bethea T, Cole S, Hudson B, Penedo F J Natl Cancer Inst. 2024; 117(3):406-422.

PMID: 39196709 PMC: 11884862. DOI: 10.1093/jnci/djae211.


The effect of intermittent fasting on preventing obesity-related early aging from a molecular and cellular perspective.

Yuliyanasari N, Rejeki P, Hidayati H, Subsomwong P, Miftahussurur M J Med Life. 2024; 17(3):261-272.

PMID: 39044934 PMC: 11262604. DOI: 10.25122/jml-2023-0370.


T cells in obesity-associated inflammation: The devil is in the details.

Valentine Y, Nikolajczyk B Immunol Rev. 2024; 324(1):25-41.

PMID: 38767210 PMC: 11694249. DOI: 10.1111/imr.13354.


References
1.
Robert L . Aging of the vascular-wall and atherosclerosis. Exp Gerontol. 2000; 34(4):491-501. DOI: 10.1016/s0531-5565(99)00030-3. View

2.
Carta G, Murru E, Banni S, Manca C . Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications. Front Physiol. 2017; 8:902. PMC: 5682332. DOI: 10.3389/fphys.2017.00902. View

3.
Frasca D, Diaz A, Romero M, Blomberg B . Human peripheral late/exhausted memory B cells express a senescent-associated secretory phenotype and preferentially utilize metabolic signaling pathways. Exp Gerontol. 2016; 87(Pt A):113-120. DOI: 10.1016/j.exger.2016.12.001. View

4.
Johnson A, Olefsky J . The origins and drivers of insulin resistance. Cell. 2013; 152(4):673-84. DOI: 10.1016/j.cell.2013.01.041. View

5.
Foster M, Hwang S, Porter S, Massaro J, Hoffmann U, Fox C . Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension. 2011; 58(5):784-90. PMC: 3204377. DOI: 10.1161/HYPERTENSIONAHA.111.175315. View